VISTAGEN THERAPEUTICS, INC. Retained Earnings
VISTAGEN THERAPEUTICS, INC. (VTGN) had Retained Earnings of -$490.35 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$490.35M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$477.32M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$461.04M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$442.14M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$490.35M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$477.32M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$461.04M 10-Q · filed 2026-02-12 | |
| 2025-09-30 | -$442.14M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$422.73M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | -$407.63M 10-K · filed 2026-06-15 | |
| 2024-12-31 | -$394.00M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | -$379.91M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$366.95M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | -$356.21M 10-K · filed 2025-06-17 | |
| 2023-12-31 | -$346.69M 10-Q · filed 2024-02-13 | |
| 2023-09-30 | -$340.34M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$333.75M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$326.85M 10-K · filed 2024-06-11 | -$326.85M 10-K · filed 2023-06-28 |
| 2022-12-31 | -$314.62M 10-Q · filed 2023-02-07 | |
| 2022-09-30 | -$304.86M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$287.38M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$267.60M 10-K · filed 2023-06-28 | |
| 2021-12-31 | -$250.92M 10-Q · filed 2022-02-10 | |
| 2021-09-30 | -$240.38M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$227.59M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | -$219.84M 10-K · filed 2022-06-23 | |
| 2020-12-31 | -$213.63M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | -$208.33M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | -$205.03M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | -$201.91M 10-K · filed 2021-06-29 | |
| 2019-12-31 | -$198.64M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | -$192.68M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | -$187.34M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | -$181.13M 10-K · filed 2020-06-29 | |
| 2018-12-31 | -$175.41M 10-Q · filed 2019-02-12 | |
| 2018-09-30 | -$168.19M 10-Q · filed 2018-10-29 | |
| 2018-06-30 | -$160.76M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$156.54M 10-K · filed 2019-06-25 | |
| 2017-12-31 | -$152.47M 10-Q · filed 2018-02-12 | |
| 2017-09-30 | -$149.26M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$144.26M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$142.00M 10-K · filed 2018-06-26 | |
| 2016-12-31 | -$139.45M 10-Q · filed 2017-02-13 | |
| 2016-09-30 | -$136.81M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$133.71M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$131.74M 10-K · filed 2017-06-29 | |
| 2015-12-31 | -$123.24M 10-Q · filed 2016-02-16 | |
| 2015-09-30 | -$121.09M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | -$114.05M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | -$84.52M 10-K · filed 2016-06-24 | |
| 2014-12-31 | -$78.30M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | -$77.21M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | -$75.19M 10-Q · filed 2014-08-12 | |
| 2014-03-31 | -$70.64M 10-K · filed 2015-06-29 | |
| 2013-12-31 | -$68.81M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | -$68.94M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | -$67.48M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | -$70.64M 10-Q · filed 2014-11-19 | -$67.67M 10-K · filed 2013-07-18 |
| 2012-12-31 | -$63.90M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | -$58.56M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$56.61M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | -$67.67M 10-Q · filed 2013-11-14 | -$54.78M 10-K · filed 2012-07-02 |
| 2011-12-31 | -$51.74M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | -$47.24M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$44.98M 10-Q · filed 2011-08-22 | |
| 2011-03-31 | -$42.57M 10-K · filed 2012-07-02 | -$42.57M 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |